Golimumab Archives - Medical Conferences

Biologics in psoriatic arthritis: where we are and where we are headed

Presented By

Dr Vinod Chandran

Conference

IFPA 2024

Type

News article

17 July 2024 11:55

How effective is dose escalation of biologicals in IBD?

Presented By

Dr Cristina Rubín de Célix, University Hospital La Princesa, Spain

Trial

RAINBOW-IBD

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:30

Early biologic therapy induces larger effect than delayed treatment in Crohn’s disease

Presented By

Prof. Shomron Ben-Horin, Tel-Aviv University, Israel

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:21

Upadacitinib appears to be an efficacious therapy for moderately-to-severely ulcerative colitis

Presented By

Prof. Remo Panaccione , University of Calgary, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:44

Guselkumab plus golimumab promising combination for ulcerative colitis

Presented By

Prof. Bruce Sands, Mount Sinai School of Medicine, NY, USA

Trial

Phase 2, VEGA

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:10

Risk of hospitalisation and surgery linked to IBD biological

Presented By

Dr Camilla Bjørn Jensen, Frederiksberg Hospital

Conference

ECCO 2021

Type

News article

2 July 2021 20:20

Vedolizumab and anti-TNF therapies: a real-world comparison

Presented By

Dr G. Mantzaris , Evangelismos Hospital, Greece

Trial

EVOLVE

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 15:35

Vedolizumab, adalimumab, and golimumab compared

Presented By

Dr F.S. Macaluso & Dr A. Casanotti

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 15:32